![]() |
Freie Universität Berlin Charité University Medicine Berlin Humboldt University Berlin Max-Delbrück-Center for Molecular Medicine, Berlin-Buch |
![]() |
| || Home || Positions || Contact || |
|
GRK 1123: |
Cellular Mechanisms of Learning and Memory Consolidation |
This Research Training Group is funded by the German Research Council DFG
| AG Ahnert-Hilger | AG Behr | AG Geiger | AG Haucke | AG Heinemann/ Kempter |
| AG Multhaup | AG Wulczyn | AG Rosenmund | AG Schmitz/ Brecht |
AG Sigrist |
Prof. Dr. rer. nat. Gerd Multhaup
Institut für Chemie-Biochemie
Freie Universität Berlin
Thielallee 63
14195 Berlin
multhaup@chemie.fu-berlin.de
Title
Toxicity of the amyloid Aß peptide: a possible role in the nucleus
Question of the projectA broad range of neurodegenerative disorders such as Alzheimer’s disease (AD) share the common feature of neuronal damage that may be caused by toxic, aggregation-prone proteins. The clinical condition of AD patients is paralleled by a synaptic pathology, which underlies the weakening in learning and memory in AD.
Non-fibrillar aggregates have been shown to be toxic to cells in culture and in vivo and to impair synaptic functions. In addition, we found that mechanisms such as oligomerization of the amyloid precursor protein (APP) itself, APP heterointeractions with APP related proteins APLP1 and APLP2 and the beta-secretase (BACE) directly influence the production of toxic peptides and were identified as risk factors.
Specific questions to be addressed are:
What determines the particular toxic effect and what is the exact mechanism?
What are the primary targets to the toxic forms and how is toxicity mediated to specific cells?
A model of pathological intraneuronal Aß oligomers was proposed, based on the occurrence of APP homodimers (Beher et al., 1996; Kaden et al., 2008; Scheuermann et al., 2001) and stabilized Aß dimers (Schmechel et al., 2003). An interaction motif within the Aß domain of the transmembrane sequence mediated homodimeric interactions of APP and strongly influenced Aß42 production (Munter et al., 2007). Early studies described soluble Aß42 oligomers as the major cause for neuronal loss in AD brains. We were able to show that the motif GxxxG is not only involved in Aß generation but also that Gly residues G29 and G33 are key residue influencing aggregation and toxicity of Aß42 (Munter et al., 2007; Harmeier et al., 2009).
Surprisingly, G33 substitutions could uncouple oligomerization from toxicity and LTP inhibition (Harmeier et al., 2009). Our results imply the existence of different types of Aß strains, some causing toxic effects and others aggregating into oligomers without adopting toxic conformations. This novel knowledge on toxic oligomers and non-toxic forms has provided us with excellent tools to investigate the primary targets to the toxic forms of Aß and to answer the question how is Aß toxicity linked to cellular mechanisms of learning and memory.
Objectives
In the present project we have discovered a possible role for Aß in gene regulation, which could either represent a new or an abnormal function of Aß. A possible function of APP in nuclear signaling was suggested for AICD (APP intracellular domain), which has been shown to translocate into the nucleus as a complex with the neuronal adaptor protein Fe65. Fe65 was shown to bind and to stabilize AICD and to associate with the histone acetyltransferase Tip60. AICD was reported to up-regulate several genes, such as KAI1, APP, BACE, neprilysin and others, whereas the lipoprotein receptor LRP1 is negatively regulated by AICD. Our novel hypothesis is that not only AICD but also Aß has a role in gene regulation. Recent results showed that Aß oligomers were rapidly internalized and transported within the cell from the cytoplasm into the nucleus. However, the exact transport mechanism remains still unclear.
We conclude that Aß42 can have a specific transcriptional regulatory function. Our data imply that deregulation of Aß target genes could be an alternative pathway for Aß-induced neurotoxicity.
The overall aim of this project is to improve our understanding of mechanisms of APP in mediating toxicity through nuclear signaling. The objectives based on our recent findings are:
Methods
Dissertation topics
Cooperation with other Members
Scholarship Holder:
| AG Ahnert-Hilger | AG Behr | AG Geiger | AG Haucke | AG Heinemann/ Kempter |
| AG Multhaup | AG Nitsch/ Wulczyn |
AG Rosenmund | AG Schmitz/ Brecht |
AG Sigrist |